Combined analysis of molecular and clinical predictors of gefitinib activity in advanced non-small cell lung cancer: Epidermal growth factor receptor mutations do not tell the whole story
Research output: Contribution to journal › Article › peer-review
13Scopus
citations
Fingerprint
Dive into the research topics of 'Combined analysis of molecular and clinical predictors of gefitinib activity in advanced non-small cell lung cancer: Epidermal growth factor receptor mutations do not tell the whole story'. Together they form a unique fingerprint.